Epidemiology of hepatitis C: geographic differences and temporal trends
about
Intrinsically unstructured domain 3 of hepatitis C Virus NS5A forms a "fuzzy complex" with VAPB-MSP domain which carries ALS-causing mutationsAlcoholic liver disease and hepatitis C: a frequently underestimated combinationHepatitis C: a review for primary care physiciansAn RNA-binding protein, hnRNP A1, and a scaffold protein, septin 6, facilitate hepatitis C virus replication.Hepatitis C virus non-structural protein NS5A interacts with FKBP38 and inhibits apoptosis in Huh7 hepatoma cellsHuman butyrate-induced transcript 1 interacts with hepatitis C virus NS5A and regulates viral replicationHepatitis C virus RNA replication is regulated by FKBP8 and Hsp90A single-amino-acid mutation in hepatitis C virus NS5A disrupting FKBP8 interaction impairs viral replicationThe human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.Inhibition of cyclophilins alters lipid trafficking and blocks hepatitis C virus secretionDiacylglycerol acyltransferase-1 localizes hepatitis C virus NS5A protein to lipid droplets and enhances NS5A interaction with the viral capsid coreHuman VAP-C negatively regulates hepatitis C virus propagationDissociation of a MAVS/IPS-1/VISA/Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavageIntramembrane processing by signal peptide peptidase regulates the membrane localization of hepatitis C virus core protein and viral propagationSystem-based proteomic analysis of the interferon response in human liver cellsRisk factors for hepatitis C virus infection among blood donors in southern Brazil: a case-control study.Tools enabling the elucidation of molecular pathways active in human disease: application to Hepatitis C virus infection.Update on hepatitis B and C virus diagnosisDermatologic Extrahepatic Manifestations of Hepatitis CEpidemiology of hepatitis C virus in IranThe role of microRNAs in human liver cancersConsensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in IndiaInhibitory Effect of 2'-Substituted Nucleosides on Hepatitis C Virus Replication Correlates with Metabolic Properties in Replicon CellsReplication fitness and NS5B drug sensitivity of diverse hepatitis C virus isolates characterized by using a transient replication assay.Inhibition of hepatitis C virus replication by antimonial compounds.Preclinical Evaluation of Two Neutralizing Human Monoclonal Antibodies against Hepatitis C Virus (HCV): a Potential Treatment To Prevent HCV Reinfection in Liver Transplant PatientsThe natural history of hepatitis C virus (HCV) infection.Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine proteaseSCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells.Initiation factor-independent translation mediated by the hepatitis C virus internal ribosome entry siteSelection and Characterization of Replicon Variants Dually Resistant to Thumb- and Palm-Binding Nonnucleoside Polymerase Inhibitors of the Hepatitis C VirusPersistent Replication of Hepatitis C Virus Replicons Expressing the -Lactamase Reporter in Subpopulations of Highly Permissive Huh7 CellsManaging Occupational Risks for Hepatitis C Transmission in the Health Care SettingLiver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis CCritical role of PA28 in hepatitis C virus-associated steatogenesis and hepatocarcinogenesisSevere fibrosis in hepatitis C virus-infected patients is associated with increased activity of the mannan-binding lectin (MBL)/MBL-associated serine protease 1 (MASP-1) complexHepatitis C Virus Replication in Transfected and Serum-Infected Cultured Human Fetal HepatocytesLiver-Infiltrating Lymphocytes in Chronic Human Hepatitis C Virus Infection Display an Exhausted Phenotype with High Levels of PD-1 and Low Levels of CD127 ExpressionEvolution of Resistant M414T Mutants among Hepatitis C Virus Replicon Cells Treated with Polymerase Inhibitor A-782759Comprehensive Analysis of the Effects of Ordinary Nutrients on Hepatitis C Virus RNA Replication in Cell Culture
P2860
Q21560973-2E0ECD48-0488-43E4-B72F-768DB1C66F50Q22305502-040BA6F5-CB89-45D7-BA29-ACA3CCB1D6B2Q22306040-9DC2CD2D-816D-4619-AD73-723EBAA3705BQ24293290-538E5E07-1594-4EE5-878B-37E0069004E9Q24297145-E07BFBCC-8209-475A-8DD0-41884AA5FA85Q24305040-BFA39CFA-2A71-4017-B89C-66210E9EB5EDQ24306116-1BDEAAC9-F42F-4C7F-9A5B-DBB04BEB27E1Q24307609-629F5113-1396-4BF1-9469-88D17068D3FCQ24307963-B26990EC-9AA0-4819-9F56-26569585E65CQ24308039-41890AC1-0339-4708-A12C-5129563E0263Q24318808-1074BB02-48A9-4619-B155-8579F8BCA618Q24337683-E3A6B720-A312-49AB-B1F1-9F273B7ECD53Q24546084-DF0A93FD-470B-4948-84CA-5994F5FB8BF4Q24658154-24259B82-675F-4067-9513-1FBAD9055E38Q24797522-43E8BFF5-A18F-4D84-ABF3-1E261B0A49BFQ24800271-82FCA9D8-09FC-4EA5-A966-A130B4DF6A35Q24815400-76821C67-2BB6-48E8-8867-ECFF2E274FA0Q26777048-6BE34224-18D2-4DC9-8692-2429D0D9C182Q26781746-1D46B26C-9FD2-44D4-A35C-8EC6819C8F64Q26781996-504C6559-62AA-45C0-B60D-4FEE4C919509Q26861699-4BE81769-35AC-4766-BDDF-4B0A85DE1BBAQ27010612-D015EEB1-4DC3-44D8-9572-9656C96E300FQ27469482-6B0E8922-CA64-4046-9000-6F1F902BD393Q27469483-FAD4BBB7-06CB-4DCA-A8F6-81BF42149BA0Q27472609-CD214C1A-C8BB-45BC-81C7-11276982E4B2Q27473046-817E2018-E8BD-42A5-ADEB-1B9D6C8781DFQ27473116-65981701-E2BD-4893-859A-034966A79323Q27473126-D28FA3A1-6CC6-4CF8-BDC0-9B88B2123F5FQ27473129-4820956F-F2E6-4852-BA47-63C75AD6C055Q27473149-3DC4C8D7-C3AF-45FD-B894-E920638F7DF1Q27473236-5834A3D2-3D4F-43CB-B597-15F64396D0C6Q27473340-86733C7B-22AC-4DD1-8619-4B94D994B409Q27477626-EBB845E5-0D88-4391-8D1A-8F576EB1EE85Q27477966-3B6D869D-0BE1-4727-BA00-904AAE7930AFQ27477993-4DD3E92E-8DDE-4187-B4F3-4A545930D8DEQ27478140-9F452EBE-C31F-42E4-B8A2-59A5FCC2720EQ27478288-A721ADB8-441C-4068-905C-EA5ABB184A65Q27478366-D678E744-2FFE-4D1A-BE79-CBBE30635ACDQ27480267-51B56B78-2B65-4219-A43E-D45F509CF382Q27480270-B8A1F038-AC1F-43D8-A8E2-B1D2B6C79A4F
P2860
Epidemiology of hepatitis C: geographic differences and temporal trends
description
2000 nî lūn-bûn
@nan
2000 թուականին հրատարակուած գիտական յօդուած
@hyw
2000 թվականին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Epidemiology of hepatitis C: geographic differences and temporal trends
@ast
Epidemiology of hepatitis C: geographic differences and temporal trends
@en
type
label
Epidemiology of hepatitis C: geographic differences and temporal trends
@ast
Epidemiology of hepatitis C: geographic differences and temporal trends
@en
prefLabel
Epidemiology of hepatitis C: geographic differences and temporal trends
@ast
Epidemiology of hepatitis C: geographic differences and temporal trends
@en
P3181
P356
P1476
Epidemiology of hepatitis C: geographic differences and temporal trends
@en
P2093
P3181
P356
10.1055/S-2000-9506
P407
P577
2000-01-01T00:00:00Z